GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Inventory-to-Revenue

Pharmaresearch Bio Co (XKRX:217950) Inventory-to-Revenue : 0.12 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharmaresearch Bio Co's Average Total Inventories for the quarter that ended in Dec. 2023 was ₩2,441 Mil. Pharmaresearch Bio Co's Revenue for the six months ended in Dec. 2023 was ₩20,031 Mil. Pharmaresearch Bio Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.12.

Pharmaresearch Bio Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 declined from Dec. 2022 (0.16) to Dec. 2022 (0.12)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pharmaresearch Bio Co's Days Inventory for the six months ended in Dec. 2023 was 58.02.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharmaresearch Bio Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 3.15.


Pharmaresearch Bio Co Inventory-to-Revenue Historical Data

The historical data trend for Pharmaresearch Bio Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Inventory-to-Revenue Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial 0.53 0.27 0.16 0.16 0.12

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue Get a 7-Day Free Trial 0.53 0.27 0.16 0.16 0.12

Competitive Comparison of Pharmaresearch Bio Co's Inventory-to-Revenue

For the Biotechnology subindustry, Pharmaresearch Bio Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's Inventory-to-Revenue falls into.



Pharmaresearch Bio Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharmaresearch Bio Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (2351.22 + 2529.812) / 2 ) / 20030.641
=2440.516 / 20030.641
=0.12

Pharmaresearch Bio Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (Q: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2022 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Revenue (Q: Dec. 2023 )
=( (2351.22 + 2529.812) / 2 ) / 20030.641
=2440.516 / 20030.641
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co  (XKRX:217950) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharmaresearch Bio Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=2440.516/7676.092*365 / 2
=58.02

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharmaresearch Bio Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2023 ) / Average Total Inventories (Q: Dec. 2023 )
=7676.092 / 2440.516
=3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines